Diabetic Ketoacidosis (DKA) — Initial Priority Intervention
Clinical Presentation & Pathophysiology
The client’s presentation of nausea, vomiting, abdominal pain, severe dehydration, and
Kussmaul respirations (rapid, deep breathing) is a classic picture of
diabetic ketoacidosis (DKA). In type 1 diabetes mellitus, an absolute insulin deficiency prevents glucose from entering cells. This forces the body into a state of cellular starvation, triggering the breakdown of fat for energy. The byproduct of this massive lipolysis is the production of
ketone bodies (acetoacetate, beta-hydroxybutyrate, and acetone), which accumulate in the blood, causing a high-anion-gap metabolic acidosis
[1]. The severe dehydration results from profound osmotic diuresis, as the kidneys attempt to excrete excess glucose and ketones, dragging water and critical electrolytes like sodium and potassium with them. This fluid loss is the primary driver of the life-threatening hypovolemia and hemodynamic instability in DKA.
Prioritization: Why Fluid Resuscitation Comes First
In the management of DKA, the immediate, life-saving priority is to restore intravascular volume. The consensus guidelines emphasize that fluid therapy must be initiated before insulin administration
[1]. The rationale is rooted in pathophysiology: severe volume depletion leads to decreased tissue perfusion, which would prevent subcutaneously or intravenously administered insulin from being effectively distributed to target tissues. Furthermore, the profound dehydration directly contributes to acute kidney injury and shock. Initiating
isotonic fluid resuscitation (
0.9% sodium chloride) expands the intravascular space, improves hemodynamic stability, and begins to lower blood glucose levels through dilution and improved renal perfusion. This step is critical to stabilize the client’s circulation and ensure that subsequent interventions, like insulin therapy, can work effectively
[1].
Analysis of Other Options
-
Administer insulin as prescribed: While insulin is the definitive treatment to halt ketogenesis and correct acidosis, its administration is dangerous and less effective in a severely hypovolemic patient. Insulin drives potassium, glucose, and fluid into the intracellular space, which can precipitate a rapid, life-threatening drop in serum potassium (
hypokalemia) and worsen hypotension if the intravascular volume is not restored first. Fluid resuscitation must precede and accompany the start of a continuous insulin infusion
[1].
-
Monitor blood glucose levels every hour: Frequent monitoring of blood glucose is a crucial ongoing assessment to guide the insulin infusion rate and prevent hypoglycemia. However, it is an assessment and monitoring action, not a direct intervention to reverse the immediate life-threat of hypovolemic shock.
-
Assess neurological status frequently: Neurological assessments are vital for detecting the rare but serious complication of
cerebral edema, particularly in pediatric populations. In an adult, while important, this assessment does not address the primary, immediate threats of circulatory collapse and severe acidosis, which are directly managed by fluid and insulin therapy.
The NCLEX-RN Clinical Judgment Model Connection
This question tests the ability to recognize and analyze cues (signs of DKA and severe dehydration) and prioritize hypotheses. The priority-setting framework in DKA management is sequential: first, address the "ABCs" and circulatory volume; second, correct the metabolic derangement. The nurse must recognize that fluid resuscitation is the foundational intervention upon which all other treatments depend. The consensus report explicitly outlines this sequence, making the establishment of IV access and initiation of fluid replacement the first and most critical nursing action
[1].
References (research sources)
- [1]
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report.GuidelineUmpierrez GE, Davis GM, ElSayed NA, Fadini GP, Galindo RJ, Hirsch IB, Klonoff DC, McCoy RG, Misra S, Gabbay RA, Bannuru RR, Dhatariya KK. (2024) · DOI: 10.2337/dci24-0032